ORIENTE, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.431
EU - Europa 643
AS - Asia 447
AF - Africa 13
Totale 2.534
Nazione #
US - Stati Uniti d'America 1.384
SG - Singapore 212
IT - Italia 210
CN - Cina 205
IE - Irlanda 84
NL - Olanda 75
FI - Finlandia 74
DE - Germania 61
UA - Ucraina 54
CA - Canada 47
SE - Svezia 40
GB - Regno Unito 23
IN - India 19
CI - Costa d'Avorio 12
FR - Francia 10
JP - Giappone 7
PL - Polonia 6
TR - Turchia 4
BG - Bulgaria 3
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
ET - Etiopia 1
Totale 2.534
Città #
Chandler 264
Singapore 171
Ashburn 112
Millbury 76
Princeton 76
Jacksonville 74
Amsterdam 72
Boston 70
Nanjing 56
Napoli 49
Ottawa 43
Santa Clara 42
Wilmington 30
Beijing 26
Pune 19
Seattle 19
Des Moines 18
Nanchang 17
Hebei 16
Naples 16
Houston 13
Lawrence 13
Tianjin 13
Shenyang 12
Boardman 9
Jiaxing 9
Falls Church 8
Kronberg 8
Kunming 8
Norwalk 8
Washington 7
Woodbridge 7
Changsha 6
Hangzhou 6
Augusta 5
Caserta 5
Dallas 5
Florence 4
Helsinki 4
Toronto 4
Zhengzhou 4
Auburn 3
Changchun 3
Crispano 3
Fairfield 3
Guangzhou 3
Hanover 3
Hicksville 3
Idstein 3
Kagoya 3
Meppel 3
Munich 3
Ningbo 3
Paris 3
Rome 3
Shenzhen 3
Sofia 3
Casoria 2
Cava de' Tirreni 2
Citta Sant'angelo 2
Dalmine 2
Dublin 2
Fort Worth 2
Frankfurt am Main 2
Hackney 2
Jinan 2
Los Angeles 2
Maddaloni 2
Osaka 2
Redmond 2
San Mateo 2
Scafati 2
Shanghai 2
Taizhou 2
Addis Ababa 1
Ann Arbor 1
Bari 1
Brescia 1
Cardito 1
Castellammare Di Stabia 1
Cava De' Tirreni 1
Chiba 1
Clifton 1
Council Bluffs 1
Falkenstein 1
Fossombrone 1
Frederiksberg 1
Fuzhou 1
Köln 1
Leawood 1
Leipzig 1
London 1
Magenta 1
Mainz 1
Melito Di Napoli 1
Milan 1
Mountain View 1
New Albany 1
Nocera Inferiore 1
Orange 1
Totale 1.532
Nome #
Prep1 Deficiency Affects Olfactory Perception and Feeding Behavior by Impairing BDNF-TrkB Mediated Neurotrophic Signaling 68
Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease 62
Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol-kinase subcellular localization. 59
PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells 56
Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. 56
Glucose regulates insulin mitogenic effect by modulating SHP-2 activation and localization in JAr cells. 49
Low Dose Bisphenol-A Regulates Inflammatory Cytokines through GPR30 in Mammary Adipose Cells 49
Insulin receptor substrate-2 phosphorylation is necessary for protein kinase czeta activation by insulin in l6hir cells. 48
Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle 46
Low-Dose bisphenol-A impairs adipogenesis and generates dysfunctional 3T3-L1 adipocytes 45
Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the Arg1152 --> Gln insulin receptor. 44
Prep1, A Homeodomain transcription factor involved in glucose and lipid metabolism 44
Differential role of insulin receptor substrate (IRS1 and IRS) in L6 skeletal muscle cells expressing the Arg1152Gln insulin receptor. 43
Prep1 deficiency improves metabolic response in white adipose tissue 43
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 42
miR-214-dependent increase of PHLPP2 levels mediates the impairment of insulin-stimulated akt activation in mouse aortic endothelial cells exposed to methylglyoxal 42
Prep1 regulates angiogenesis through a PGC-1α-mediated mechanism 42
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 42
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 40
Glucose regulates insulin mitogenic effect by modulating SHP-2 activation and localization in JAr cells 39
In L6 cells, glucose induces cytosolic translocation of PKC alpha, trans-activates the insulin receptor kinase and regulates its own uptake 39
The Relevance of Insulin Action in the Dopaminergic System 39
In skeletal muscle, advanced glycation end products inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. 37
Peroxisome Proliferator-Activated Receptor γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 expression in skeletal muscle cells. Evidence for involvement of Activator Protein-1. 36
Differential role of IRS-1 and IRS-2 in L6 muscle cells expressing the ARG(1152)-> GLN insulin receptor. 35
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 35
Insulin-activated PKCb bypasses Ras and stimulates MAPKinase activity and cell proliferation in muscle cells 34
Glucose regulates insulin mitogenic effect by modulating SHP-2 activation and localization in JAr cells. 34
Insulin induces the interaction of IRS-1 with PKC-alpha and 14-3-3-epsilon 34
PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms 34
Zoonotic Risk of Encephalitozoon cuniculi in Animal-Assisted Interventions: Laboratory Strategies for the Diagnosis of Infections in Humans and Animals 34
Activation and mitochondrial translocation of protein kinase Cdelta are necessary for insulin stimulation of pyruvate dehydrogenase complex activity in muscle and liver cells 33
Bisphenol-A Impairs Insulin Action and Up-Regulates Inflammatory Pathways in Human Subcutaneous Adipocytes and 3T3-L1 Cells. 33
Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains 33
Phosphorylation and Signalling of the Insulin Receptor are Controlled by a Basic AminoAcid Motif. 32
Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1 32
Interleukin 6 reduces vascular smooth muscle cell apoptosis via Prep1 and is associated with aging 32
Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism 31
Dolichol reverts lovastatin-induced inhibition of insulin action on glycogen synthesis but not on cell cycle regulation, in skeletal muscle and liver cells 31
Insulin receptor internalization and intracellular sorting are regulated by protein kinase C-zeta and protein kinase b/Akt. 31
Cytokine signature and COVID-19 prediction models in the two waves of pandemics 30
Cultured beta cells PED overexpression alters intracellular calcium levels thereby impairing glucose induced insulin secretion 29
Implication of the nlrp3 inflammasome in bovine age‐related sarcopenia 29
In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routine. 28
In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing 28
In L6 skeletal muscle cells, glucose induces cytosolic translocation of Protein Kinase C-alfa and trans-activates the insulin receptor kinase. 28
Anti-skeletal muscle antibodies in sera of dogs with leishmaniasis. 28
In L6 skeletal muscle tells advanced glycation end products inhibit insulin action by activating src and inducing the formation of a multi-molecular complex 27
PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation. 26
Glucose-transport Is Genetically Altered In Subjects With Type-ii Diabetes (niddm) 26
In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing 25
Low-dose bisphenol-a promotes epigenetic changes at pparγ promoter in adipose precursor cells 25
Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. 24
Protein Kinase B/Akt Binds and Phosphorylates PED/PEA-15, Stabilizing Its Antiapoptotic Action 24
Platelet - Rich Plasma Increases Growth and Motility of Adipose Tissue - Derived Mesenchymal Stem Cells and Controls Adipocyte Secretory Function 24
Prep1 controls insulin glucoregulatory function in liver by transcriptional targetting of SHP1 tyrosine phosphatase. 24
Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling 23
Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15 23
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase 23
Antagonism between Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) and Chicken Ovalbumin Upstream Promoter-Transcription Factor 2 (COUP-TFII) modulates Ped/Pea-15 gene expression 23
SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review 22
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. 22
Receptor-mediated internalization of insulin: potential role of pp120/HA4, a substrate of the insulin receptor kinase 22
Thiazolidinediones control the expression of phosphoprotein enriched in diabetes (ped/pea-15) both in vitro and in vivo 22
Ped/pea-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells 21
PDK1 interaction with insulin receptor and tyrosine phosphorylation are required for insulin metabolic action. 21
Protein kinase C-zeta and protein kinase B regulate distinct steps of insulin endocytosis and intracellular sorting 20
PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis 20
Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. 20
Thiazolidinediones control the expression of Ped/Pea-15 (phosphoprotein enriched in diabetes) both in vitro and in vivo 20
PED/PEA-15 controls TGFbeta production and fibronectin secretion through a PLD/PKCbeta pathway 20
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. 19
Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action 19
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction 19
The function of PED, a novel gene in type 2 diabetes 19
Insulin stimulates phosphoinositides-dependent kinase (PDK)-1 binding to insulin-receptor C-terminus followed by tyrosine-phosphorylation and activation. 19
Thrombin-activated platelets enhance healing of ulcerative skin lesion by inducing IGF-1 release by skin fibroblasts 19
PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice. 19
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 19
Leishmania spp.-infected dogs have circulating anti-skeletal muscle autoantibodies recognizing serca1 19
null 18
TGF beta impairs muscle differentiation and induces autophagy by PED/PEA-15-mediated pathway 18
Transforming growth factor-beta increases the expression of PED/PEA-15 and glucose uptake via smad-3 phosphorylation in l6 cells 17
Substrate-zymography: a still worthwhile method for gelatinases analysis in biological samples 17
The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes 17
The PED/PEA-15 diabetogene as a potential thiazolidinedione target 16
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of PED/PEA-15 gene 15
Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development 15
Resveratrol Improves Endothelial Function by A PREP1-Mediated Pathway in Mouse Aortic Endothelial Cells 14
Mouse models of insulin resistance 14
In skeletal muscle cells advanced glycation end products inhibit insulin action by inducing the formation of a multi-molecular complex which includes RAGE, PKCalpha and IRS1 13
null 12
Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targetting of SHP1 Tyrosine Phosphatase 11
EVOO Polyphenols Exert Anti-Inflammatory Effects on the Microglia Cell through TREM2 Signaling Pathway 10
The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver 7
Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells 6
Totale 2.776
Categoria #
all - tutte 13.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020133 0 0 11 8 16 2 0 1 7 15 33 40
2020/2021265 19 11 59 15 18 32 60 3 22 2 22 2
2021/2022564 5 0 9 4 12 18 12 16 89 36 145 218
2022/2023591 96 61 25 25 74 74 3 40 87 68 26 12
2023/2024427 12 56 34 26 36 75 6 58 8 10 75 31
2024/2025278 141 121 16 0 0 0 0 0 0 0 0 0
Totale 2.776